State Street’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.5M | Buy |
1,384,254
+81,715
| +6% | +$1.09M | ﹤0.01% | 2231 |
|
|
2025
Q1 | $13.3M | Buy |
1,302,539
+99,156
| +8% | +$1.01M | ﹤0.01% | 2355 |
|
|
2024
Q4 | $19M | Buy |
1,203,383
+89,793
| +8% | +$1.42M | ﹤0.01% | 2254 |
|
|
2024
Q3 | $64.7M | Sell |
1,113,590
-107,786
| -9% | -$6.26M | ﹤0.01% | 1568 |
|
|
2024
Q2 | $55.8M | Sell |
1,221,376
-341,519
| -22% | -$15.6M | ﹤0.01% | 1617 |
|
|
2024
Q1 | $103M | Buy |
1,562,895
+508,528
| +48% | +$33.7M | ﹤0.01% | 1282 |
|
|
2023
Q4 | $41.9M | Buy |
1,054,367
+152,367
| +17% | +$6.06M | ﹤0.01% | 1798 |
|
|
2023
Q3 | $28.8M | Sell |
902,000
-113,903
| -11% | -$3.63M | ﹤0.01% | 1948 |
|
|
2023
Q2 | $40.8M | Buy |
1,015,903
+71,744
| +8% | +$2.88M | ﹤0.01% | 1792 |
|
|
2023
Q1 | $40.3M | Sell |
944,159
-23,979
| -2% | -$1.02M | ﹤0.01% | 1794 |
|
|
2022
Q4 | $46.5M | Buy |
968,138
+34,626
| +4% | +$1.66M | ﹤0.01% | 1689 |
|
|
2022
Q3 | $35.1M | Sell |
933,512
-57,240
| -6% | -$2.15M | ﹤0.01% | 1850 |
|
|
2022
Q2 | $27.4M | Buy |
990,752
+307,105
| +45% | +$8.49M | ﹤0.01% | 2024 |
|
|
2022
Q1 | $37.2M | Buy |
683,647
+28,655
| +4% | +$1.56M | ﹤0.01% | 1940 |
|
|
2021
Q4 | $38.3M | Sell |
654,992
-22,276
| -3% | -$1.3M | ﹤0.01% | 1999 |
|
|
2021
Q3 | $26.8M | Sell |
677,268
-1,710
| -0.3% | -$67.6K | ﹤0.01% | 2268 |
|
|
2021
Q2 | $28.8M | Sell |
678,978
-44,845
| -6% | -$1.9M | ﹤0.01% | 2266 |
|
|
2021
Q1 | $44.6M | Buy |
723,823
+297,732
| +70% | +$18.3M | ﹤0.01% | 1819 |
|
|
2020
Q4 | $30.1M | Buy |
426,091
+326,865
| +329% | +$23.1M | ﹤0.01% | 1979 |
|
|
2020
Q3 | $3.83M | Buy |
99,226
+14,215
| +17% | +$548K | ﹤0.01% | 2915 |
|
|
2020
Q2 | $3.19M | Buy |
+85,011
| New | +$3.19M | ﹤0.01% | 2990 |
|